Coherus Oncology, Inc. (CHRS)
1.07
+0.04
(+3.88%)
USD |
NASDAQ |
Oct 13, 16:00
1.06
-0.01
(-0.93%)
After-Hours: 20:00
Coherus Oncology EPS Diluted (TTM) : -1.021 for June 30, 2026
EPS Diluted (TTM) Chart
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.021 |
| March 31, 2026 | -1.246 |
| December 31, 2025 | -1.456 |
| September 30, 2025 | -1.585 |
| June 30, 2025 | -1.367 |
| March 31, 2025 | -1.333 |
| December 31, 2024 | -1.295 |
| September 30, 2024 | -1.571 |
| June 30, 2024 | -1.893 |
| March 31, 2024 | -2.062 |
| December 31, 2023 | -2.566 |
| September 30, 2023 | -2.607 |
| June 30, 2023 | -3.316 |
| March 31, 2023 | -3.472 |
| December 31, 2022 | -3.760 |
| September 30, 2022 | -3.600 |
| June 30, 2022 | -2.973 |
| March 31, 2022 | -2.722 |
| December 31, 2021 | -3.853 |
| September 30, 2021 | -3.134 |
| June 30, 2021 | -2.327 |
| March 31, 2021 | -1.266 |
| December 31, 2020 | 1.587 |
| September 30, 2020 | 1.964 |
| June 30, 2020 | 2.275 |
| Date | Value |
|---|---|
| March 31, 2020 | 1.932 |
| December 31, 2019 | 1.165 |
| September 30, 2019 | -0.2552 |
| June 30, 2019 | -1.752 |
| March 31, 2019 | -2.755 |
| December 31, 2018 | -3.206 |
| September 30, 2018 | -3.127 |
| June 30, 2018 | -3.35 |
| March 31, 2018 | -3.75 |
| December 31, 2017 | -4.55 |
| September 30, 2017 | -5.42 |
| June 30, 2017 | -2.66 |
| March 31, 2017 | -3.30 |
| December 31, 2016 | -3.43 |
| September 30, 2016 | -3.07 |
| June 30, 2016 | -6.60 |
| March 31, 2016 | -6.44 |
| December 31, 2015 | -5.99 |
| September 30, 2015 | -6.11 |
| June 30, 2015 | -6.04 |
| March 31, 2015 | -5.259 |
| December 31, 2014 | -4.795 |
| September 30, 2014 | -3.781 |
| June 30, 2014 | -2.660 |
| March 31, 2014 | -2.154 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Enanta Pharmaceuticals, Inc. | -2.411 |
| ACADIA Pharmaceuticals, Inc. | 2.220 |
| Alnylam Pharmaceuticals, Inc. | 5.923 |
| Anika Therapeutics, Inc. | -0.2741 |
| Savara, Inc. | -0.5766 |